ROCKET AF试验中的即时华法林监测 - Suppr

Suppr

超能文献

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

作者信息

Patel Manesh R, Hellkamp Anne S, Fox Keith A A

机构信息

Duke Clinical Research Institute, Durham, NC

University of Edinburgh, Edinburgh, United Kingdom.

出版信息

N Engl J Med. 2016 Feb 25;374(8):785-8. doi: 10.1056/NEJMc1515842. Epub 2016 Feb 3.

DOI:10.1056/NEJMc1515842

PMID:26839968

Abstract

摘要

相似文献

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Feb 25;374(8):785-8. doi: 10.1056/NEJMc1515842. Epub 2016 Feb 3.

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Jul 28;375(4):390-1. doi: 10.1056/NEJMc1604020. Epub 2016 Jul 6.

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Jul 28;375(4):390. doi: 10.1056/NEJMc1604020.

Stroke prevention in non-valvular atrial fibrillation with rivaroxaban.

Cardiovasc J Afr. 2014 Jul-Aug;25(4):196.

[The ROCKET AF study].

G Ital Cardiol (Rome). 2012 Sep;13(9):553-6. doi: 10.1714/1133.12482.

Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.

Expert Rev Cardiovasc Ther. 2012 Aug;10(8):965-72. doi: 10.1586/erc.12.91.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2334-5; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2334; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2333; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2333-4; author reply 2335. doi: 10.1056/NEJMc1112233.

引用本文的文献

Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review.

Thromb Haemost. 2025 May;125(5):405-420. doi: 10.1055/a-2407-1400. Epub 2024 Aug 30.

Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Clin Pharmacol Ther. 2021 Jun;109(6):1593-1605. doi: 10.1002/cpt.2131. Epub 2021 Jan 19.

Hemostasis-On-a-Chip: Impedance Spectroscopy Meets Microfluidics for Hemostasis Evaluation.

Micromachines (Basel). 2019 Aug 14;10(8):534. doi: 10.3390/mi10080534.

[Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Med Klin Intensivmed Notfmed. 2018 May;113(4):284-292. doi: 10.1007/s00063-018-0436-8. Epub 2018 May 4.

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Ther Adv Chronic Dis. 2017 Dec;8(12):165-176. doi: 10.1177/2040622317720106. Epub 2017 Jul 26.

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

BMC Cardiovasc Disord. 2017 Sep 6;17(1):238. doi: 10.1186/s12872-017-0672-5.

Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.

J Comp Eff Res. 2017 Sep;6(6):549-560. doi: 10.2217/cer-2017-0025. Epub 2017 Jul 24.

Drug therapy in anticoagulation: which drug for which patient?

Clin Med (Lond). 2017 Jun;17(3):233-244. doi: 10.7861/clinmedicine.17-3-233.

Management strategies for atrial fibrillation.

J R Soc Med. 2017 Jan;110(1):13-22. doi: 10.1177/0141076816677857.

Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation With Direct Oral Anticoagulants. Is One Of These Not Like The Others?

J Atr Fibrillation. 2016 Aug 31;9(2):1481. doi: 10.4022/jafib.1481. eCollection 2016 Aug-Sep.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Feb 25;374(8):785-8. doi: 10.1056/NEJMc1515842. Epub 2016 Feb 3.

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Jul 28;375(4):390-1. doi: 10.1056/NEJMc1604020. Epub 2016 Jul 6.

Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.

N Engl J Med. 2016 Jul 28;375(4):390. doi: 10.1056/NEJMc1604020.

Stroke prevention in non-valvular atrial fibrillation with rivaroxaban.

Cardiovasc J Afr. 2014 Jul-Aug;25(4):196.

[The ROCKET AF study].

G Ital Cardiol (Rome). 2012 Sep;13(9):553-6. doi: 10.1714/1133.12482.

Rivaroxaban for stroke prevention in atrial fibrillation: a critical review of the ROCKET AF trial.

Expert Rev Cardiovasc Ther. 2012 Aug;10(8):965-72. doi: 10.1586/erc.12.91.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2334-5; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2334; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2333; author reply 2335. doi: 10.1056/NEJMc1112233.

Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.

N Engl J Med. 2011 Dec 15;365(24):2333-4; author reply 2335. doi: 10.1056/NEJMc1112233.

引用本文的文献

Handheld Point-of-Care Devices for Snakebite Coagulopathy: A Scoping Review.

Thromb Haemost. 2025 May;125(5):405-420. doi: 10.1055/a-2407-1400. Epub 2024 Aug 30.

Thromboembolic and Hemorrhagic Outcomes in the Direct Oral Anticoagulant Trials Across the Spectrum of Kidney Function.

Clin Pharmacol Ther. 2021 Jun;109(6):1593-1605. doi: 10.1002/cpt.2131. Epub 2021 Jan 19.

Hemostasis-On-a-Chip: Impedance Spectroscopy Meets Microfluidics for Hemostasis Evaluation.

Micromachines (Basel). 2019 Aug 14;10(8):534. doi: 10.3390/mi10080534.

[Hemorrhage under direct oral anticoagulants : Occurrence and treatment in intensive care patients].

Med Klin Intensivmed Notfmed. 2018 May;113(4):284-292. doi: 10.1007/s00063-018-0436-8. Epub 2018 May 4.

Navigating the choice of oral anticoagulation therapy for atrial fibrillation in the NOAC era.

Ther Adv Chronic Dis. 2017 Dec;8(12):165-176. doi: 10.1177/2040622317720106. Epub 2017 Jul 26.

Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation.

BMC Cardiovasc Disord. 2017 Sep 6;17(1):238. doi: 10.1186/s12872-017-0672-5.

Comparative effectiveness of rivaroxaban in the treatment of nonvalvular atrial fibrillation.

J Comp Eff Res. 2017 Sep;6(6):549-560. doi: 10.2217/cer-2017-0025. Epub 2017 Jul 24.

Drug therapy in anticoagulation: which drug for which patient?

Clin Med (Lond). 2017 Jun;17(3):233-244. doi: 10.7861/clinmedicine.17-3-233.

Management strategies for atrial fibrillation.

J R Soc Med. 2017 Jan;110(1):13-22. doi: 10.1177/0141076816677857.

Reducing The Risk Of Stroke In Patients With Nonvalvular Atrial Fibrillation With Direct Oral Anticoagulants. Is One Of These Not Like The Others?

J Atr Fibrillation. 2016 Aug 31;9(2):1481. doi: 10.4022/jafib.1481. eCollection 2016 Aug-Sep.